Blue Note Therapeutics, a prescription digital therapeutics company, now offers Attune, the first cancer-specific prescription digital treatment for cancer-related mental health, to qualified Oncology Institute patients.
Attune provides self-directed tools based on established face-to-face therapies. It also features a virtual support group where cancer patients can connect whenever they wish.
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
